These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects. Yuan CS Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023 [TBL] [Abstract][Full Text] [Related]
8. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety. Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology, diagnosis, and management of opioid-induced constipation. Farmer AD; Holt CB; Downes TJ; Ruggeri E; Del Vecchio S; De Giorgio R Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):203-212. PubMed ID: 29870734 [TBL] [Abstract][Full Text] [Related]
11. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives. Mehta V; Alaward S; Kuravinakop S; Nikolic S Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899 [TBL] [Abstract][Full Text] [Related]
12. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs. Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866 [TBL] [Abstract][Full Text] [Related]
13. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone. Morlion B; Clemens KE; Dunlop W Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959 [TBL] [Abstract][Full Text] [Related]
14. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation. Jones R; Prommer E; Backstedt D Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678 [TBL] [Abstract][Full Text] [Related]
15. Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study. Hermanns K; Junker U; Nolte T Expert Opin Pharmacother; 2012 Feb; 13(3):299-311. PubMed ID: 22224497 [TBL] [Abstract][Full Text] [Related]
17. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group. Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449 [TBL] [Abstract][Full Text] [Related]
18. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects. Yuan CS J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815 [TBL] [Abstract][Full Text] [Related]
19. Narcotic bowel syndrome and opioid-induced constipation. Szigethy E; Schwartz M; Drossman D Curr Gastroenterol Rep; 2014 Oct; 16(10):410. PubMed ID: 25183577 [TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain. Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]